米乐m6
米乐m6:About Henlius
米乐m6:Company Profile
米乐m6:Corporate Culture
Honor
Board of Directors
米乐m6:Management Team
Advisory Committee
Product
米乐m6:Marketed Products
米乐m6:Products in R&D
米乐m6:Clinical Trial
Science & Technology
R&D Result
米乐m6:Innovation Centre
Technology Platform
Quality Management
Manufacturing
米乐m6:Collaborations
Investor Relations
Information Disclosure
米乐m6:Corporate Governance
米乐m6:Financial Reports
米乐m6:Stock Info
IR Calendar
米乐m6:Investor Presentation
Analyst Coverage
米乐m6:Contact Information
Media
Press Release
Multi-media
Media Reports
米乐m6:Media Enquiry
Careers
Talent Philosophy
米乐m6:Staff Life
米乐m6:Training and Development
Contact Us
米乐m6:Contact Information
Customer Message
Privacy
米乐m6:Legal Statement
米乐m6:Compliance
EN
简体
EN
繁體
Home
About Henlius
米乐m6:Company Profile
米乐m6:Corporate Culture
Honor
Board of Directors
Management Team
Advisory Committee
Product
Marketed Products
Products in R&D
Clinical Trial
米乐m6:Science & Technology
米乐m6:R&D Result
米乐m6:Innovation Centre
米乐m6:Technology Platform
米乐m6:Quality Management
Manufacturing
米乐m6:Collaborations
Investor Relations
米乐m6:Information Disclosure
Listing Documents
米乐m6:Announcement & Circulars
米乐m6:Corporate Governance
Financial Reports
Stock Info
IR Calendar
米乐m6:Investor Presentation
Analyst Coverage
Contact Information
Media
米乐m6:Press Release
2022
2021
2020
2019
2018
2017
2016
2015
2014
Multi-media
Company
Event
Popular Science
Media Reports
米乐m6:Media Enquiry
Careers
米乐m6:Talent Philosophy
Staff Life
米乐m6:Training and Development
米乐m6:Job Opportunities
米乐m6:Contact Us
米乐m6:Contact Information
Customer Message
Privacy
Legal Statement
Compliance
Be the most trusted biotech company
米乐m6:Press Release
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Multi-media
Company
米乐m6:Popular Science
Highlights
Download
Media Reports
Media Enquiry
2024-03-04
Henlius Forecasts Profit in 2023: Achieving first full year of profitability, and ushering in a new phase of high-quality development
2024-02-29
Henlius Adalimumab Biosimilar Received sNDA Acceptance Notification from the NMPA
2024-02-19
ASTRUM-004 Featured on the Cover of Cancer Cell
2024-02-01
Henlius Announces Successful Completion of Phase 1 PK Similarity Clinical Study of Denosumab HLX14
2024-01-25
First International Shipment of HANSIZHUANG
2024-01-17
Results from Clinical Trials of Two Henlius’ Novel Products Released at ASCO GI 2024
2024-01-11
Henlius and Sermonix Announce Strategic Collaboration and Exclusive License Agreements for Novel Endocrine Therapy Lasofoxifene
2024-01-05
Cancer Cell Published the Results of ASTRUM-004: HANSIZHUANG Combined with Chemotherapy for the First-line Treatment of sqNSCLC
2024-01-03
Henlius to Release Clinical Data at 2024 ASCO GI
1
2
3
...
31
var _hmt = _hmt || []; (function() { var hm = document.createElement("script"); hm.src = "https://hm.baidu.com/hm.js?90c4d9819bca8c9bf01e7898dd269864"; var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s); })(); !function(p){"use strict";!function(t){var s=window,e=document,i=p,c="".concat("https:"===e.location.protocol?"https://":"http://","sdk.51.la/js-sdk-pro.min.js"),n=e.createElement("script"),r=e.getElementsByTagName("script")[0];n.type="text/javascript",n.setAttribute("charset","UTF-8"),n.async=!0,n.src=c,n.id="LA_COLLECT",i.d=n;var o=function(){s.LA.ids.push(i)};s.LA?s.LA.ids&&o():(s.LA=p,s.LA.ids=[],o()),r.parentNode.insertBefore(n,r)}()}({id:"K9y7iMpaU8NS42Fm",ck:"K9y7iMpaU8NS42Fm"});
米乐m6登录 - m6平台 - 米乐m6
米乐m6 - 米乐m6登陆
米乐m6app下载
米乐m6平台 - 官方下载 - 米乐m6在线登录
一分赛车_米乐m6_一分赛车官网